This liquid biopsy test analyzes key genetic alterations in 7 genes via DNA sequencing and 6 genes via RNA sequencing linked to lung cancer. It detects single nucleotide variations (SNVs), copy number variations (CNVs), insertions/deletions (InDels), and gene fusions—all from a simple blood sample.
Patients with lung cancer who cannot undergo a tissue biopsy or need a less invasive method for diagnosis, monitoring, or treatment planning.
